Search results
Founder of the Oxford Robotics Institute
- Prof. Paul Newman is the founder of the Oxford Robotics Institute, as well as the founder of Oxbotica Ltd. He is the BP Professor of Information Engineering at the University of Oxford and inventor of techniques that allow machines to know where they are, what surrounds them and what they should do next.
ori.ox.ac.uk/people/paul-newman/
Overview. Bill is Professor of Translational Genomic Medicine in The Manchester Centre for Genomic Medicine at the University of Manchester and Honorary Consultant at Manchester University NHS Foundation Trust.
Jul 11, 2024 · The Academy of Medical Science has elected Professor Bill Newman, Consultant in Genomic Medicine, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, to its prestigious Fellowship, in recognition of his many achievements and outstanding contributions to research in pharmacogenetics and rare conditions.
Professor Bill Newman studied Medicine at Manchester University and completed training in adult medicine before training in Clinical Genetics. He has a PhD on the Genetics of Osteoarthritis.
Apr 1, 2022 · Professor Bill Newman, a consultant in genomic medicine at Manchester University NHS Foundation Trust and Professor of Translational Genomic Medicine at the University of Manchester, led the Pharmacogenetics to Avoid Loss of Hearing (PALoH) study.
Professor Bill Newman. Qualifications: MA FRCP PhD. Registration: GMC 3617744. Professional bodies: British Society for Genetic Medicine (Chair of Scientific Program Committee), American Society of Human Genetics, European Society of Human Genetics (Board member).
The Academy of Medical Science has elected Professor Bill Newman, Professor of Translational Genomic Medicine at The University of Manchester to its prestigious Fellowship, in recognition of his many achievements and outstanding contributions to research in pharmacogenetics and rare conditions.
Professor Newman is a Professor of Translational Genomic Medicine at the University of Manchester, and Consultant in Genomic Medicine at Manchester University NHS Foundation Trust .
